1988
DOI: 10.1007/bf03026887
|View full text |Cite
|
Sign up to set email alerts
|

Anticholinergic drugs and anaesthesia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1990
1990
2002
2002

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 29 publications
0
1
0
Order By: Relevance
“…Low doses of romifidine (5 µg kg −1 ) appeared to have less pronounced cardiovascular effects than low doses of medetomidine, despite similar levels of sedation (Pypendop & Verstegen 2001). Anticholinergic premedication has also been recommended with α 2 ‐agonists to prevent bradyarrhythmias and, potentially, the reduction in cardiac output produced by these agents (Mirakhur 1988). However, the anticholinergic‐induced increase in heart rate does not ensure an improvement in overall cardiac performance, and may actually potentiate α 2 ‐adrenoreceptor mediated hypertension (Dunkle et al.…”
Section: Introductionmentioning
confidence: 99%
“…Low doses of romifidine (5 µg kg −1 ) appeared to have less pronounced cardiovascular effects than low doses of medetomidine, despite similar levels of sedation (Pypendop & Verstegen 2001). Anticholinergic premedication has also been recommended with α 2 ‐agonists to prevent bradyarrhythmias and, potentially, the reduction in cardiac output produced by these agents (Mirakhur 1988). However, the anticholinergic‐induced increase in heart rate does not ensure an improvement in overall cardiac performance, and may actually potentiate α 2 ‐adrenoreceptor mediated hypertension (Dunkle et al.…”
Section: Introductionmentioning
confidence: 99%